Anticoagulants



Anticoagulants





DANGEROUS DRUG

PREGNANCY CATEGORY C (HEPARIN, APIXABAN, DABIGATRAN, RIVAROXABAN)

PREGNANCY CATEGORY X (WARFARIN)

PREGNANCY CATEGORY B (LOW–MOLECULAR-WEIGHT HEPARINS)


Therapeutic Actions

Oral anticoagulants interfere with the hepatic synthesis of vitamin K–dependent clotting factors (factors II, prothrombin, VII, IX, and X), resulting in their eventual depletion and prolongation of clotting times; parenteral anticoagulants interfere with the conversion of prothrombin to thrombin, blocking the final step in clot formation but leaving the circulating levels of clotting factors unaffected.


Indications



  • Treatment and prevention of pulmonary embolism and venous thrombosis and its extension


  • Treatment of atrial fibrillation with embolization


  • Prevention of DVT


  • Prophylaxis of systemic embolization after acute MI


  • Prevention of thrombi following specific surgical procedures and prolonged bed rest (low–molecular-weight heparins)


  • Unlabeled uses: Prevention of recurrent TIAs and MI




Adverse Effects



  • Bleeding: Hemorrhage; GI or urinary tract bleeding (hematuria, dark stools; paralytic ileus; intestinal obstruction from hemorrhage into GI tract); petechiae and purpura, bleeding from mucous membranes; hemorrhagic infarction, vasculitis, skin necrosis of female breast; adrenal hemorrhage and resultant adrenal insufficiency; compressive neuropathy secondary to hemorrhage near a nerve


  • Dermatologic: Alopecia, urticaria, dermatitis


  • GI: Nausea, vomiting, anorexia, abdominal cramping, diarrhea, retroperitoneal hematoma, hepatitis, jaundice, mouth ulcers


  • GU: Priapism, nephropathy, red-orange urine


  • Hematologic: Granulocytosis, leukopenia, eosinophilia


  • Other: Fever, “purple toes” syndrome

Jul 20, 2016 | Posted by in NURSING | Comments Off on Anticoagulants

Full access? Get Clinical Tree

Get Clinical Tree app for offline access